Rethinking Preclinical Testing – The DART Advantage
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.
Add to cart failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
Rethinking Preclinical Testing – The DART Advantage
-
Narrated by:
-
Written by:
About this listen
What if you could rethink preclinical testing — beyond animal models, beyond limitations? Join us for the first episode of our podcast, "Rethinking Preclinical Testing – The DART Advantage," featuring Dr. Subhadra Dravida, Founder & CEO, Transcell Biologics, as the guest speaker, in a powerful conversation with our host, Barinder Marhok, Global Head – Healthcare & Life Sciences, Quantiphi. Discover the Phi Moment – the breakthrough realization that led to DART, an AI-powered, stem cell-based platform that's rewriting the future of preclinical testing: faster, scalable, and more ethical.
Visit www.quantiphi.com for more information.
Hosted on Acast. See acast.com/privacy for more information.
No reviews yet